Tau Oligomer Pathology in Nucleus Basalis Neurons During the Progression of Alzheimer Disease
Open Access
- 25 January 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Neuropathology & Experimental Neurology
- Vol. 77 (3) , 246-259
Abstract
Although tau is the primary constituent of neurofibrillary tangles (NFTs), evidence suggests that its toxic moiety is oligomeric in Alzheimer disease (AD). In this regard, tau oligomers correlate more strongly with neuronal loss than NFTs and exhibit neurotoxicity in preclinical AD models. Here, we investigated the spatiotemporal progression of oligomeric tau accumulation within the highly vulnerable cholinergic neurons of the nucleus basalis of Meynert (nbM) in AD. Tissue from subjects who died with a clinical diagnosis of no cognitive impairment, mild cognitive impairment, or AD was immunostained with the tau oligomeric complex 1 (TOC1) antibody, a marker of tau oligomers, and p75NTR, a cholinergic cell marker. Stereological estimates revealed a significant increase in the number of TOC1 nbM immunopositive (+) neurons with a concomitant decrease in p75NTR+ nbM neurons during the transition from mild cognitive impairment to AD. Immunofluorescence identified TOC1+ neurons that colocalized with the pretangle tau marker phospho-Ser422, which persisted into late stage NFTs immunoreactive for MN423. Analysis of the nbM subfields revealed a topographical caudal to rostral gradient of TOC1+ neurons during disease progression. Taken together, these data suggest that toxic tau oligomers accumulate caudorostrally in selectively vulnerable nbM neurons during the onset of AD.Keywords
Funding Information
- NIH (AG014449, AG053581, AG053760, NS082730, AG044372)
This publication has 105 references indexed in Scilit:
- Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transportNeurobiology of Aging, 2012
- Preclinical AD Workgroup staging: pathological correlates and potential challengesNeurobiology of Aging, 2012
- Progression of Tau Pathology in Cholinergic Basal Forebrain Neurons in Mild Cognitive Impairment and Alzheimer's DiseaseThe American Journal of Pathology, 2011
- Heat Shock Protein 70 Prevents both Tau Aggregation and the Inhibitory Effects of Preexisting Tau Aggregates on Fast Axonal TransportBiochemistry, 2011
- Characterization of Prefibrillar Tau Oligomers in Vitro and in Alzheimer DiseaseJournal of Biological Chemistry, 2011
- Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type miceMolecular Neurodegeneration, 2011
- Reduction of Basal Forebrain Cholinergic System Parallels Cognitive Impairment in Patients at High Risk of Developing Alzheimer's DiseaseCerebral Cortex, 2009
- Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer diseaseNeurobiology of Aging, 2009
- Tau Suppression in a Neurodegenerative Mouse Model Improves Memory FunctionScience, 2005
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991